Last updated on December 2018

A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)


Brief description of study

The purpose of this study is to investigate the safety and efficacy for 52-week dosing of JR-131 in renal anemia patients with chronic kidney disease (CKD).

Clinical Study Identifier: NCT02912533

Contact Investigators or Research Sites near you

Start Over

Kissei Pharmaceutical Co., Ltd

Tokyo and Other Japanese Cities, Japan

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.